Product Code: ETC13339833 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Mannose Phosphate Isomerase Deficiency Market was valued at USD 0.32 Billion in 2024 and is expected to reach USD 0.47 Billion by 2031, growing at a compound annual growth rate of 15.49% during the forecast period (2025-2031).
Mannose Phosphate Isomerase Deficiency (MPI-CDG) is a rare genetic disorder that affects the body`s ability to produce functional proteins. The global market for MPI-CDG is relatively small, primarily due to the rarity of the condition. However, with advancements in genetic testing and increasing awareness among healthcare professionals, the market is expected to witness steady growth in the coming years. Currently, there are limited treatment options available for MPI-CDG, leading to a significant unmet medical need. Pharmaceutical companies are increasingly investing in research and development efforts to develop targeted therapies for MPI-CDG, which is likely to drive market growth. Additionally, collaborations between key stakeholders, including healthcare providers, researchers, and patient advocacy groups, are playing a crucial role in advancing the understanding and management of MPI-CDG globally.
The Global Mannose Phosphate Isomerase Deficiency market is witnessing significant growth due to increasing awareness and diagnosis of this rare genetic disorder. With advancements in genetic testing technologies, more patients are being identified, driving the demand for treatment options. The development of novel therapies targeting the underlying molecular mechanisms of the disease presents a promising opportunity for pharmaceutical companies to enter this niche market. Additionally, collaborations between research institutions and industry players are facilitating the discovery of potential therapeutic targets and accelerating the drug development process. As regulatory agencies prioritize orphan diseases and offer incentives for drug development, there is a favorable environment for investment and innovation in the Mannose Phosphate Isomerase Deficiency market. Companies focusing on precision medicine and gene therapy are well-positioned to capitalize on these emerging trends and address the unmet medical needs of patients with this rare disorder.
The Global Mannose Phosphate Isomerase Deficiency Market faces several challenges, including limited awareness among healthcare professionals and patients about this rare genetic disorder, leading to underdiagnosis and delayed treatment initiation. Additionally, the high cost of treatment options and lack of specific therapies for this condition pose significant hurdles for patients and healthcare providers. Another challenge is the limited availability of specialized medical centers with expertise in managing Mannose Phosphate Isomerase Deficiency, resulting in difficulties accessing appropriate care. Moreover, the small patient population makes it challenging for pharmaceutical companies to invest in research and development efforts to develop new treatments, further limiting therapeutic options for individuals affected by this rare disorder. Addressing these challenges will require collaborative efforts among stakeholders to improve diagnosis rates, expand treatment options, and enhance support services for patients with Mannose Phosphate Isomerase Deficiency.
The global Mannose Phosphate Isomerase Deficiency market is primarily driven by increasing awareness among healthcare professionals and patients about this rare genetic disorder, leading to improved diagnosis and treatment options. Additionally, ongoing advancements in genetic testing technologies and personalized medicine approaches are facilitating early detection of the disease, thereby driving market growth. Moreover, rising investments in research and development activities focused on developing novel therapies and potential cures for Mannose Phosphate Isomerase Deficiency are further propelling the market forward. The growing prevalence of this disorder, particularly in pediatric populations, is also contributing to the demand for effective treatment options, driving market expansion. Overall, a combination of these factors is expected to fuel the growth of the Mannose Phosphate Isomerase Deficiency market in the coming years.
Government policies related to the Global Mannose Phosphate Isomerase Deficiency market primarily focus on promoting research and development in the field of rare genetic disorders. Governments around the world have implemented initiatives to increase funding for scientific research, clinical trials, and treatment options for patients with Mannose Phosphate Isomerase Deficiency. Additionally, regulatory agencies such as the FDA in the United States and the EMA in Europe have established orphan drug programs to incentivize pharmaceutical companies to develop therapies for rare diseases like Mannose Phosphate Isomerase Deficiency. These policies aim to improve access to innovative treatments, support patient advocacy groups, and ultimately enhance the quality of life for individuals affected by this rare genetic disorder.
The Global Mannose Phosphate Isomerase Deficiency market is expected to witness steady growth in the coming years due to increasing awareness about the rare genetic disorder and advancements in diagnostic techniques. The market is likely to be driven by the development of novel treatment options and therapies that target the underlying genetic cause of the disease. Additionally, collaborations between pharmaceutical companies and research institutions are expected to further propel market growth by bringing innovative solutions to the forefront. With a growing emphasis on personalized medicine and precision healthcare, the Global Mannose Phosphate Isomerase Deficiency market is poised for expansion as more resources are dedicated to understanding and addressing this rare disorder.
In the global Mannose Phosphate Isomerase Deficiency market, Asia is poised for significant growth due to improving healthcare infrastructure and rising awareness about rare genetic disorders. North America remains a key market with a high prevalence of genetic disorders and advanced healthcare facilities. In Europe, increasing research initiatives and government support for rare diseases drive market growth. The Middle East and Africa region is witnessing a gradual rise in diagnosis rates and treatment options for rare genetic disorders. Latin America shows potential for market expansion with growing investments in healthcare and increasing access to advanced therapies. Overall, global efforts to raise awareness about Mannose Phosphate Isomerase Deficiency and improve diagnostic capabilities are driving market growth across all regions.
Global Mannose Phosphate Isomerase Deficiency Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Mannose Phosphate Isomerase Deficiency Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, 2021 & 2031F |
3.3 Global Mannose Phosphate Isomerase Deficiency Market - Industry Life Cycle |
3.4 Global Mannose Phosphate Isomerase Deficiency Market - Porter's Five Forces |
3.5 Global Mannose Phosphate Isomerase Deficiency Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Mannose Phosphate Isomerase Deficiency Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Mannose Phosphate Isomerase Deficiency Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Global Mannose Phosphate Isomerase Deficiency Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Global Mannose Phosphate Isomerase Deficiency Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Mannose Phosphate Isomerase Deficiency Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Mannose Phosphate Isomerase Deficiency Market Trends |
6 Global Mannose Phosphate Isomerase Deficiency Market, 2021 - 2031 |
6.1 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Genetic Disorder, 2021 - 2031 |
6.1.3 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Metabolic Disease, 2021 - 2031 |
6.1.4 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Rare Disease, 2021 - 2031 |
6.2 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Enzyme Replacement Therapy, 2021 - 2031 |
6.2.3 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Supportive Therapy, 2021 - 2031 |
6.2.4 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Gene Therapy, 2021 - 2031 |
6.3 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.3.4 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Injection, 2021 - 2031 |
6.4 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Hospitals & Clinics, 2021 - 2031 |
6.4.3 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Research & Diagnostic Centers, 2021 - 2031 |
6.4.4 Global Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Pharmaceutical & Biotechnology, 2021 - 2031 |
7 North America Mannose Phosphate Isomerase Deficiency Market, Overview & Analysis |
7.1 North America Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, 2021 - 2031 |
7.2 North America Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.5 North America Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 North America Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Mannose Phosphate Isomerase Deficiency Market, Overview & Analysis |
8.1 Latin America (LATAM) Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
8.5 Latin America (LATAM) Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.6 Latin America (LATAM) Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Mannose Phosphate Isomerase Deficiency Market, Overview & Analysis |
9.1 Asia Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
9.5 Asia Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.6 Asia Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Mannose Phosphate Isomerase Deficiency Market, Overview & Analysis |
10.1 Africa Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
10.5 Africa Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.6 Africa Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Mannose Phosphate Isomerase Deficiency Market, Overview & Analysis |
11.1 Europe Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
11.5 Europe Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.6 Europe Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Mannose Phosphate Isomerase Deficiency Market, Overview & Analysis |
12.1 Middle East Mannose Phosphate Isomerase Deficiency Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
12.5 Middle East Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.6 Middle East Mannose Phosphate Isomerase Deficiency Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Mannose Phosphate Isomerase Deficiency Market Key Performance Indicators |
14 Global Mannose Phosphate Isomerase Deficiency Market - Export/Import By Countries Assessment |
15 Global Mannose Phosphate Isomerase Deficiency Market - Opportunity Assessment |
15.1 Global Mannose Phosphate Isomerase Deficiency Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Mannose Phosphate Isomerase Deficiency Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Mannose Phosphate Isomerase Deficiency Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
15.4 Global Mannose Phosphate Isomerase Deficiency Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.5 Global Mannose Phosphate Isomerase Deficiency Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Mannose Phosphate Isomerase Deficiency Market - Competitive Landscape |
16.1 Global Mannose Phosphate Isomerase Deficiency Market Revenue Share, By Companies, 2024 |
16.2 Global Mannose Phosphate Isomerase Deficiency Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |